UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6026
Gaia
GAIA
$48.4M
| $121K | ﹤0.01% |
27,392
+14,086
| +106% | +$58.7K |
|
6027
Custom Truck One Source
CTOS
$2.37B
| $121K | ﹤0.01% |
27,733
-23,307
| -46% | -$113K |
|
6028
HCM Defender 500 Index ETF
LGH
$602M
| $121K | ﹤0.01% |
2,437
+2,367
| +3,381% | +$110K |
|
|
TBI
6029
Trueblue
TBI
$311M
| $120K | ﹤0.01% |
11,695
-55,464
| -83% | -$601K |
|
6030
Nu Skin
NUS
$267M
| $120K | ﹤0.01% |
11,386
-87,137
| -88% | -$1.1M |
|
6031
KRONOS Worldwide
KRO
$989M
| $120K | ﹤0.01% |
9,548
-28,707
| -75% | -$362K |
|
6032
Insteel Industries
IIIN
$625M
| $120K | ﹤0.01% |
3,868
-10,052
| -72% | -$330K |
|
6033
NACCO Industries
NC
$320M
| $120K | ﹤0.01% |
4,325
-1,973
| -31% | -$59.9K |
|
6034
First Trust Securitized Plus ETF
DEED
$64.5M
| $120K | ﹤0.01% |
5,799
+5,013
| +638% | +$103K |
|
6035
HCM Defender 100 Index ETF
QQH
$763M
| $120K | ﹤0.01% |
+1,944
| New | +$109K |
|
|
SKE
6036
Skeena Resources
SKE
$4.04B
| $119K | ﹤0.01% |
22,247
+6,552
| +42% | +$30.9K |
|
6037
Air T
AIRT
$86.1M
| $119K | ﹤0.01% |
5,600
| – | – |
|
6038
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.13B
| $119K | ﹤0.01% |
3,971
-2,258
| -36% | -$66.7K |
|
6039
Ranpak Holdings
PACK
$473M
| $119K | ﹤0.01% |
18,558
-30,650
| -62% | -$207K |
|
6040
Grupo Cibest SA
CIB
$21.1B
| $119K | ﹤0.01% |
3,649
-18,825
| -84% | -$646K |
|
6041
Neuronetics
STIM
$166M
| $119K | ﹤0.01% |
66,179
+61,665
| +1,366% | +$178K |
|
6042
Lantern Pharma
LTRN
$36.5M
| $119K | ﹤0.01% |
25,500
| – | – |
|
6043
James River Group Holdings
JRVR
$217M
| $119K | ﹤0.01% |
15,376
-35,222
| -70% | -$289K |
|
6044
Global X FTSE Southeast Asia ETF
ASEA
$102M
| $119K | ﹤0.01% |
8,165
+81
| +1% | +$1.2K |
|
6045
HBT Financial
HBT
$1.32B
| $119K | ﹤0.01% |
5,805
-9,975
| -63% | -$190K |
|
6046
DXP Enterprises
DXPE
$2.98B
| $118K | ﹤0.01% |
2,576
-19,616
| -88% | -$991K |
|
|
JHS
6047
John Hancock Income Securities Trust
JHS
$127M
| $118K | ﹤0.01% |
10,826
-2,446
| -18% | -$27K |
|
|
NVRO
6048
DELISTED
NEVRO CORP.
NVRO
| $118K | ﹤0.01% |
14,003
-25,006
| -64% | -$267K |
|
|
ECC
6049
Eagle Point Credit Company
ECC
$513M
| $118K | ﹤0.01% |
11,716
-5,430
| -32% | -$55.1K |
|
|
HCOM
6050
DELISTED
Hartford Schroders Commodity Strategy ETF
HCOM
| $118K | ﹤0.01% |
7,738
-81,486
| -91% | -$1.25M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.